Table 1.
Clinicopathological and radiological characteristics of the patients who were diagnosed with prostate cancer
| Prebiopsy serum PSA (ng/ml), median (IQR) | 6.9 (5.2-10) | |
| PSA density, median (IQR) | 0.17 (0.12-0.30) | |
| Digital rectal exam a,N (%) | ||
| Benign | 34 (43) | |
| Malignant | 38 (48) | |
| Dubious | 6 (7.5) | |
| Missing | 2 (2.5) | |
| MRI result, N (%) | ||
| PI-RADS 3 | 7 (8.8) | |
| PI-RADS 4 | 35 (44) | |
| PI-RADS 5 | 37 (46) | |
| Radiological tumor stage, N (%) | ||
| mT2 | 58 (73) | |
| mT3a | 18 (23) | |
| mT3b | 4 (5.0) | |
| Pathology results | Bilateral SBx + TBx | Ipsilateral SBx + TBx |
| Highest ISUP, N (%) | ||
| ISUP 1 | 0 | 0 |
| ISUP 2 | 35 (48) | 37 (46) |
| ISUP 3 | 23 (29) | 21 (26) |
| ISUP 4 | 6 (7.5) | 6 (7.5) |
| ISUP 5 | 16 (20) | 16 (20) |
| Positive biopsy cores, mean (% of total biopsies) | 7 (47) | 6 (67) |
| Presence of cribriform growth a,N (%) | ||
| Yes | 29 (36) | |
| No | 18 (23) | |
| Missing | 33 (41) | |
IQR = interquartile range; ISUP = International Society of Urological Pathology; MRI = magnetic resonance imaging; PI-RADS = Prostate Imaging Reporting and Data System; PSA = prostate-specific antigen; SBx = systematic biopsy; TBx = target biopsy.
a
Information known only for bilateral SBx +TBx results.